Genomic organization and mutation analysis of three candidate genes for hereditary neuralgic amyotrophy

Muscle and Nerve

Volumn 29, Issue 4, 2004, Pages 601-604

  Hünermund, Gert ^a   Schirmacher, Anja ^a   Ringelstein, Bernd ^a   Young, Peter ^a   Watts, Giles D ^c   Meuleman, Jan ^b,c   Nelis, Eva ^b   Chance, Phillip F ^c   Timmerman, Vincent ^b   Stögbauer, Florian ^a   Kuhlenbäumer, Gregor ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cytoglobin (CYGB); Hereditary neuralgic amyotrophy (HNA); Mutation analysis; Sphingosine kinase 1 (SPHK1); Tissue inhibitor of metalloproteinase 2 (TIMP2)

Indexed keywords

COMPLEMENTARY DNA; CYTOGLOBIN; DNA; GLOBIN; SPHINGOSINE KINASE; SPHINGOSINE KINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; BRACHIAL PLEXUS; CANDIDATE GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CYGB GENE; DNA SEQUENCE; GENE; GENE MUTATION; GENETIC DISORDER; GENOME; HEREDITARY NEURALGIC AMYOTROPHY; HUMAN; MUSCLE ATROPHY; NEUROPATHY; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPHK1 GENE; TIMP2 GENE;

AMINO ACID SUBSTITUTION; BRACHIAL PLEXUS NEURITIS; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; EXONS; GENETIC SCREENING; GENOMIC LIBRARY; GLOBINS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 11144355259     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20009     Document Type: Article

References (19)

1. Burmester T, Ebner B, Weich B, Hankeln T. Cytoglobin: a novel globin type ubiquitously expressed in vertebrate tissues. Mol Biol Evol 2002;19:416-421.
2. Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000;15:7-12.
3. Florea L, Hartzell G, Zhang Z, Rubin GM, Miller W. A computer program for aligning a cDNA sequence with a genomic DNA sequence. Genome Res 1998;8:967-974.
4. Kawada N, Kristensen DB, Asahina K, Nakatani K, Minamiyama Y, Seki S, Yoshizato K. Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells. J Biol Chem 2001;276: 25318-25323.
5. Klein CJ, Dyck PJ, Friedenberg SM, Burns TM, Windebank AJ. Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J Neurol Neurosurg Psychiatry 2002; 73:45-50.
6. Kuhlenbaumer G, Meuleman J, De Jonghe P, Falck B, Young P, Hunermund G, Van Broeckhoven C, Timmerman V, Stogbauer F. Hereditary neuralgic amyotrophy (HNA) is genetically heterogeneous. J Neurol 2001;248:861-865.
7. Kuhlenbaeumer G, Meuleman J, Schirmacher A, Stoegbauer F, Ringelstein EB, Wehnert M, Hoeltzenbein M, Broeckhoven CV, Timmerman V. Mutation analysis of a putative sialyltransferase gene, the SFRS2 splicing factor gene and the c-myb ET-locus in two families with hereditary neuralgic amyotrophy (HNA). Ann Hum Genet 1998;62:397-400.
8. Melendez AJ, Carlos-Dias E, Gosink M, Allen JM, Takacs L. Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 2000;251:19-26.
9. Meuleman J, Kuhlenbaumer G, Audenaert D, Hunermund G, Hor H, Young P, Stogbauer F, Ringelstein EB, Van Broeckhoven C, De Jonghe P, Timmerman V. Mutation analysis of 4 candidate genes for hereditary neuralgic amyotrophy (HNA). Hum Genet 2001;108:390-393.
10. Meuleman J, Kuhlenbaumer G, Schirmacher A, Wehnert M, De Jonghe P, De Vriendt E, Young P, Airaksinen E, Pou-Serradell A, Prats JM, Ringelstein B, Stogbauer F, Van Broeckhoven C, Timmerman V. Genetic refinement of the hereditary neuralgic amyotrophy (HNA) locus at chromosome 17q25. Eur J Hum Genet 1999;7:920-927.
11. Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S, Spiegel S. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 1999; 147:545-558.
12. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 1998;152:729-741.
13. Pellegrino JE, Rebbeck TR, Brown MJ, Bird TD, Chance PF. Mapping of hereditary neuralgic amyotrophy (familial brachial plexus neuropathy) to distal chromosome 17q. Neurology 1996;46:1128-1132.
14. Redford EJ, Smith KJ, Gregson NA, Davies M, Hughes P, Gearing AJ, Miller K, Hughes RA. A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis. Brain 1997;120:1895-1905.
15. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132: 365-386.
16. Spiegel S. Sphingosine 1-phosphate: a prototype of a new class of second messengers. J Leukoc Biol 1999;65:341-344.
17. Stogbauer F, Young P, Timmerman V, Spoelders P, Ringelstein EB, Van Broeckhoven C, Kurlemann G. Refinement of the hereditary neuralgic amyotrophy (HNA) locus to chromosome 17q24-q25. Hum Genet 1997;99:685-687.
18. Watts GD, O'Briant KC, Chance PF. Evidence of a founder effect and refinement of the hereditary neuralgic amyotrophy (HNA) locus on 17q25 in American families. Hum Genet 2002;110:166-172.
19. Watts GD, O'Briant KC, Borreson TE, Windebank AJ, Chance PF. Evidence for genetic heterogeneity in hereditary neuralgic amyotrophy. Neurology 2001;56:675-678.